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Summary: 38 
During infection, increasing pathogen load stimulates both protective and harmful aspects of 39 
the host response. The dynamics of this interaction are hard to quantify in humans, but doing 40 
so could improve understanding of mechanisms of disease and protection. We sought to 41 
model the contributions of parasite multiplication rate and host response to observed parasite 42 
load in individual subjects with Plasmodium falciparum malaria, using only data obtained at 43 
the time of clinical presentation, and then to identify their mechanistic correlates. We 44 
predicted higher parasite multiplication rates and lower host responsiveness in severe malaria 45 
cases, with severe anemia being more insidious than cerebral malaria. We predicted that 46 
parasite growth-inhibition was associated with platelet consumption, lower expression of 47 
CXCL10 and type-1 interferon-associated genes, but increased cathepsin G and matrix 48 
metallopeptidase 9 expression. We found that cathepsin G and matrix metallopeptidase 9 49 
directly inhibit parasite invasion into erythrocytes. Parasite multiplication rate was associated 50 
with host iron availability and higher complement factor H levels, lower expression of 51 
gametocyte-associated genes but higher expression of translation-associated genes in the 52 
parasite. Our findings demonstrate the potential of using explicit modelling of pathogen load 53 
dynamics to deepen understanding of host-pathogen interactions and identify mechanistic 54 
correlates of protection. 55 
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Introduction: 56 
Improved methods are needed to identify mechanisms which protect against human 57 
infectious diseases in order to develop better vaccines and therapeutics1,2. Pathogen load is 58 
associated with the severity of many infections3, and is a consequence of how fast the 59 
pathogen can replicate, how long the infection has been ongoing, and the inhibition or killing 60 
of pathogen by the host response (Fig. 1a). The contribution of these factors varies within an 61 
individual over the course of infection, as well as between individuals. Identifying 62 
mechanistic correlates of the processes which determine pathogen load is likely to be more 63 
informative than identifying correlates of pathogen load per se. However, in humans the 64 
timing of infection is rarely known and treatment cannot usually be withheld to observe the 65 
natural dynamics of pathogen load and host response. Here we present an approach to 66 
estimate the latent determinants of parasite load dynamics. We use these estimates to better 67 
understand severe malaria phenotypes and to identify mechanisms inhibiting parasite growth 68 
and controlling parasite multiplication during Plasmodium falciparum malaria in Gambian 69 
children.  70 
 71 
Results: 72 
Estimating determinants of parasite load and host response dynamics in humans 73 
To estimate the determinants of parasite load dynamics in naturally-infected malaria patients 74 
we calibrated a statistical prediction model using outputs from a mechanistic simulation 75 
which combined information from two datasets. A historical dataset of the longitudinal 76 
course of untreated infection in 97 patients who were deliberately inoculated with P. 77 
falciparum as a treatment for neurosyphilis (malariatherapy dataset) (Supplementary Fig.1) 78 
5 
 
was used as a reference for changes in parasite load over time4. A dataset from 139 naturally 79 
infected Gambian children with malaria (Gambian dataset, Supplementary Table 1, 80 
Supplementary Dataset 1) was used for subsequent discovery of the determinants of parasite 81 
load dynamics. We used an existing mathematical model for the malariatherapy data (the 82 
Dietz model4), which estimated latent variables thought to determine changes in parasite load 83 
over time in each individual, and modified the model to better represent the features of the 84 
Gambian dataset. We used the modified model to simulate a large number of in-silico 85 
Gambian patients, with all latent variables and course of infection fully known, and then 86 
trained a statistical model to learn from these simulations the relationships between variables 87 
available in the real Gambian patient data and the unobservable, latent variables.  88 
In the models4, the increase in parasite load up to the first peak is determined by two 89 
individual-specific latent variables (Fig. 1b, see Methods): the within-host multiplication rate, 90 
m, which is the initial rate of increase in parasite load before any constraint by the host 91 
response; and the parasite load required to stimulate a host response that reduces parasite 92 
growth by 50%, Pc,
4. When m, Pc, and parasite load are known, parasite growth inhibition 93 
(PGI) by the host response can be calculated (see Methods). We allowed rescaling of Pc 94 
values between the malariatherapy and Gambian datasets, and incorporated plasma Tumour 95 
Necrosis Factors (TNF) concentrations as an indicator of the protective host response5,6, 96 
using a maximum-likelihood approach (see Methods and Supplementary Fig. 2). These 97 
modifications resulted in higher Pc values in the Gambian population than malariatherapy 98 
subjects, consistent with epidemiological data showing higher fever thresholds in P. 99 
falciparum infected children than in adults7. Other model assumptions and definitions are 100 
shown in Supplementary Table 2.   101 
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To test whether combination of a mechanistic simulation model with statistical learning of 102 
the relationships between latent and directly observable variables was better at predicting the 103 
determinants of parasite load than using observable variables alone, we simulated 2000 104 
Gambian children with malaria with known values of m, Pc, parasite biomass, duration of 105 
illness and plasma TNF (Fig. 1c and Supplementary Fig. 3) and then fit general additive 106 
models (GAMs) to predict values of m and Pc for individual children (Supplementary Table 107 
3). The resulting models produced more accurate predictions of of m and Pc than using 108 
individual variables alone (Fig. 1d).  109 
Next we used the GAMs to predict values of Pc and m for each of the 139 individuals in the 110 
Gambian dataset (Fig. 1e-k, Supplementary Fig. 4). Children with the most severe 111 
manifestations of malaria (SM2) had the highest parasite load, TNF, predicted m, and 112 
predicted Pc values, intermediate values were seen in those with prostration as the only 113 
manifestation of severe disease (SM1), and values were lowest in uncomplicated malaria 114 
(UM), whilst duration of illness did not differ significantly by clinical phenotype (Fig. 1e-i). 115 
These observations suggest that high parasite load and severe disease are most likely in 116 
individuals with either fast replicating parasites (high m) or less immune responsiveness (high 117 
Pc). 118 
Since age can be a major determinant of malaria severity and naturally acquired immunity8, 119 
we examined whether age was associated with m or Pc. Age was not significantly correlated 120 
with m but was significantly negatively correlated with Pc (Fig. 1j,k). This implies little age-121 
related acquisition of constitutive resistance (for example, naturally-acquired antibody-122 
mediated immunity) in these children, as might be expected from the relatively low malaria 123 
transmission in this region of The Gambia9. However, these data also indicate that a lower 124 
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parasite load would be needed to provoke an equivalent host response in older individuals 125 
without significant naturally acquired immunity.   126 
Predicting severe malaria phenotype from within-host dynamics 127 
We next asked whether individual estimates of m and Pc could be used to predict 128 
pathophysiological features malaria which had not been used in our model derivation. Severe 129 
malarial anemia (hemoglobin concentration <5g/dL), is most common in the youngest 130 
children in high transmission settings, but rare in lower transmission settings such as Greater 131 
Banjul region of The Gambia, where cerebral malaria was relatively more common10. Severe 132 
malarial anemia is characterised by a higher parasite biomass10-12, lower levels of both TNF 133 
and interleukin-10 (IL-10), but an elevated ratio of TNF:IL-1013,14 when compared to cerebral 134 
malaria. In our Gambian subjects, hemoglobin concentration could be predicted from 135 
estimated Pc, m and age; IL-10 concentration could be predicted from m and Pc 136 
(Supplementary Table 4, Fig. 2a-b). We simulated a population of Gambian infants, selected 137 
those predicted to have hemoglobin <5 g/dL, and compared their characteristics to real 138 
Gambian subjects with cerebral malaria. The simulated severe anemia cases had lower m but 139 
similar Pc, higher parasite biomass and longer duration of illness than the cerebral malaria 140 
patients (Fig 2c-f). Both TNF and IL-10 concentrations were predicted to be lower in severe 141 
anemia than in cerebral malaria (Fig 2g-h), whereas the TNF:IL-10 ratio was predicted to be 142 
higher in severe anemia (Fig 2i), supporting the biological plausibility of relationships 143 
defined in our model and illuminating a potential explanation for these distinct severe malaria 144 
phenotypes.   145 
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Estimating parasite growth inhibition reveals the protective effect of platelets 146 
The role of the host response in restricting parasite load is often unclear in human malaria 147 
because the strongest host responses are often seen in patients with the highest parasite loads 148 
and most severe disease15,16. For example platelets directly inhibit parasite growth16,17, and 149 
the reduction in platelet count typically seen in malaria is partly a consequence of the 150 
protective mechanism of platelet adhesion to infected red cells16. However the reduction in 151 
platelet count is greatest in individuals with the highest parasite load and most severe 152 
disease18, which seems counterintuitive if the low platelet counts indicate parasite killing. In 153 
Gambian children, estimated PGI did not differ significantly by clinical phenotype (Fig. 3a) 154 
indicating that the components of the host response which restrain parasite growth are 155 
similarly activated in severe and uncomplicated disease groups at the time of hospital 156 
presentation, but implying that this response developed too late to prevent high parasite load 157 
in the severe cases. Subjects with severe disease had the lowest platelet counts (Fig. 3b and 158 
Supplementary Table 1) and the highest parasite loads (Fig. 1d), but the protective role of 159 
platelets was evident through the significant (P=0.0001) correlation with PGI (Fig. 3c). Thus 160 
considering differences between individuals in observed parasite load and host response as 161 
part of a dynamic rather than static process can resolve counterintuitive associations.   162 
Predicting mechanistic correlates of parasite growth inhibition  163 
To determine whether our model-derived estimates could be used to discover aspects of host-164 
parasite interaction we sought to identify mechanistic correlates of protection and 165 
susceptibility. We analysed human whole blood gene expression, with gene signature-based 166 
deconvolution to adjust for leukocyte-mixture19, from samples of 24 children at the time of 167 
presentation (13 with UM, 11 with SM, Supplementary Table 5). Of 11702 detected human 168 
genes, 51 were significantly correlated (26 positively, 25 negatively) with estimated PGI after 169 
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adjustment for false discovery rate (Benjamini-Hochberg adjusted P<0.05, Fig. 4a, 170 
Supplementary Table 6). We reasoned that genes positively correlated with PGI should be 171 
enriched for effector mechanisms which act to reduce parasite load, whilst genes negatively 172 
correlated with PGI should be enriched for mechanisms which favour increase in parasite 173 
load. Eight of these genes were also correlated with parasite biomass and three with TNF 174 
(Supplementary Table 6).  175 
Genes positively correlated with PGI (Fig 4a) showed limited canonical pathway enrichments 176 
(Supplementary Table 7) but 16 (62%) were linked together in a network around extracellular 177 
signal-regulated kinases ERK1/2 and AKT serine/threonine kinase (Fig. 4b). These kinases 178 
integrate cellular inflammatory and metabolic responses to control innate defence 179 
mechanisms such as cytokine secretion, phagocytosis and degranulation20,21. The 25 genes 180 
negatively correlated with PGI were strongly enriched in immune response pathways 181 
(Supplementary Table 7). Network analysis showed 15 (60%) of the negatively correlated 182 
genes were linked through a network focussed around type 1 interferon (Fig. 4c), consistent 183 
with observations that sustained type 1 interferon signalling is associated with higher 184 
parasitemia in mice22-25  and potentially in humans22,26. C-X-C motif chemokine ligand 10 185 
(CXCL10, also known as IFN-γ-inducible protein of 10 kDa, IP-10) expression had the 186 
greatest log-fold change of the genes negatively correlated with PGI (Fig. 4c), consistent with 187 
findings that CXCL10 deletion and neutralisation decrease parasite load in mice27.  188 
We investigated whether associations with PGI were dependent on assumptions we made 189 
about the true severity rate in Gambian children, which we assumed to be 5% based on 190 
published data in other settings28,29. Varying this to credible extremes of 1% and 10% and 191 
repeating the process of calibration between datasets, fitting of models to predict m and Pc, 192 
and estimating new values for PGI, resulted in little difference in the genes identified as 193 
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significantly associated with PGI, or the significance of individual genes (Supplementary 194 
Table 8).    195 
Cathepsin G and MMP9 directly inhibit parasite growth 196 
The 26 genes positively correlated with PGI have not, to our knowledge, previously been 197 
described as having anti-parasitic effects so we sought direct biological evidence, focussing 198 
on two encoding secreted proteins as the best candidates: CTSG (cathepsin G) and MMP9 199 
(matrix metallopeptidase 9, also known as matrix metalloproteinase 9 and gelatinase B), 200 
which both encode neutrophil granule proteins30. We tested whether these proteases could 201 
inhibit parasite growth in vitro. Cathepsin G and MMP9 both inhibited growth of P. 202 
falciparum 3D7 strain (Fig. 5a). Addition of cathepsin G to schizont cultures produced a 203 
dramatic reduction in invasion of new erythrocytes, and pretreatment of erythrocytes with 204 
cathepsin G before adding them to schizont cultures produced a similar reduction in their 205 
invasion (Fig. 5b), indicating that cathepsin G acts primarily on the erythrocyte. Addition of 206 
MMP9 to schizont cultures produced a more modest reduction, whilst pretreatment of 207 
erythrocytes did not reduce invasion, implying that MMP9 likely acts against schizonts or 208 
free merozoites rather than preventing invasion at the erythrocyte surface (Fig. 5b).  209 
In order to identify biologically relevant concentrations of cathepsin G and MMP9 we 210 
measured their concentrations in whole blood from healthy donors, before and after 211 
stimulating degranulation, and in plasma from children with malaria at the time of clinical 212 
presentation (Fig. 5c). Local concentrations which might occur in vivo, adjacent to 213 
degranulating neutrophils, could be at least an order of magnitude higher31. MMP9 is also 214 
known to be released from other cell types in response to P. falciparum, including vascular 215 
endothelial cells32. MMP9 dose-dependently inhibited parasite growth over a physiological 216 
range of concentrations (Fig. 5d). Similarly, parasite invasion was dose-dependently inhibited 217 
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by cathepsin G pre-treatment of erythrocytes, with similar effects in each of four parasite 218 
strains with different invasion phenotypes33 (Fig. 5e). Combined treatment with low doses of 219 
MMP9 and cathepsin G – in the range detected in patient plasma – showed an additive effect 220 
(Fig. 5f).  221 
Cathepsin G has previously been reported to cleave red cell surface glycophorins34, therefore 222 
we asked whether it might also cleave other RBC surface proteins which are used as invasion 223 
receptors by P. falciparum35. Consistent with its broad inhibition of parasite invasion, 224 
cathepsin G dose-dependently cleaved the majority of P. falciparum invasion receptors 225 
including glycophorins A, B, and C, CD147 (basigin), CD108 (semaphorin 7A), and 226 
complement receptor 1 (CR1), but not CD55 (DAF) (Fig. 5g). MMP9 did not cleave any of 227 
these surface receptors (Supplementary Fig. 5). PMA stimulation of healthy donor whole 228 
blood recapitulated the loss of erythrocyte surface glycophorins A and B, CD108 and CD147 229 
in all donors, decreased glycophorin C expression in 6 of 8 healthy donors, but did not 230 
consistently reduce CR1 (Fig. 5h) (as might be expected from the dose-response curves, Fig 231 
5g). In samples from Gambian children on the day of presentation with P. falciparum 232 
malaria, the proportions of erythrocytes with detectable expression of glycophorins A and B 233 
and CD147 were significantly lower than in convalescent samples (28 days after treatment), 234 
and there was a trend to lower expression of CD108 and glycophorin C (Fig. 5i).  These 235 
results would be consistent with cleavage of these surface molecules in vivo during acute 236 
infection. The variable expression seen at day 28 (Fig. 5i) may indicate the persistence of 237 
modified erythrocytes in the circulation. The importance of glycophorins and basigin in RBC 238 
invasion and genetic susceptibility to severe malaria is well established36-38, and so it is 239 
highly likely that the cleavage of these erythrocyte receptors by cathepsin G would have a 240 
protective effect in vivo.  241 
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Host and parasite factors associated with parasite multiplication rate 242 
In our model, m is influenced by constitutive host and parasite factors but independent of any 243 
parasite load-dependent responses. We sought to confirm associations with two constitutive 244 
host factors known to influence parasite growth: iron39 and complement factor H (FH)40,41 245 
(Supplementary Dataset 1). Since we did not have premorbid blood samples we used 246 
convalescent blood as a proxy for pre-infection status, with samples collected 28 days after 247 
treatment when the host response was quiescent (median C-reactive protein 1.1mcg/mL (IQR 248 
0.5-5.1, n=70), similar to healthy West African population levels42).  249 
Iron deficiency is protective against malaria43 and reduces parasite multiplication in vitro39. 250 
Consistent with this, levels of hepcidin (a regulator of iron metabolism and marker of iron 251 
sufficiency or deficiency44) were significantly correlated with m (rs=0.21, P=0.049) in 92 252 
children who had not received blood transfusion.  253 
FH is a constitutive negative regulator of complement activation which protects host cells 254 
from complement mediated lysis45 but many pathogens including P. falciparum have evolved 255 
FH binding proteins to benefit from this protection40,41. FH protects blood-stage parasites 256 
from complement mediated killing in vitro40,41 and higher plasma levels are associated with 257 
susceptibility and severity of malaria46. In the 14 children with residual day 28 plasma 258 
available, FH correlated with m (rs=0.75, P=0.002), providing further support that the 259 
quantitative estimates from our model exhibit expected relationships with known 260 
determinants of parasite growth. 261 
We investigated whether we could identify any parasite processes associated with m, through 262 
correlation with parasite gene expression. Of 3704 parasite genes detected by RNA-Seq, 263 
adjusted for developmental stage distribution19, no individual genes passed the FDR adjusted 264 
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P-value threshold of <0.05. Therefore we used weighted gene correlation network analysis to 265 
reduce dimensionality47, generating 17 modules of co-expressed parasite genes. Module 266 
eigengene values19 of two modules correlated with m (unadjusted Spearman correlation 267 
P<0.05); their hub-genes were PF3D7_1136000 (a conserved Plasmodium protein of 268 
unknown function) and PF3D7_1238300 (putative pre-mRNA-splicing factor CWC22). The 269 
PF3D7_1136000 module was negatively correlated (rs=-0.5, P=0.01) with m and contained 270 
140 genes with greatest gene ontology enrichment in microtubule-based movement 271 
(Supplementary Tables 9 & 10). The PF3D7_1136000 module genes have high tolerance to 272 
insertional mutagenesis (Fig. 6a) and high parasite fitness following mutation (Fig. 6b), 273 
characteristics of winning mutants in competitive growth assays48, supporting the concept 274 
that lower expression of these genes may favour more rapid growth. 77 (55%) of the genes in 275 
this module exhibit greatest expression during gametocyte development49, consistent with the 276 
concept that increased sexual-stage commitment results in reduced asexual replication50. In 277 
contrast, the PF3D7_1238300 module was positively correlated with m (rs=0.46, P=0.03), 278 
and contained 45 genes enriched in translation functions (Supplementary Tables 9 & 10), 279 
plausible determinants of m, with mutagenesis tolerance typical of essential genes (Fig. 6a,b). 280 
Parasite genes differentially expressed between severe and uncomplicated malaria cases19 281 
were highly over-represented in this module (16 of 45 (36%), P=1.2x10-8, Fisher exact test). 282 
Discussion: 283 
Using a model-based approach to estimate the within-host dynamics of pathogen load and its 284 
determinants in human infection we could estimate the relative contributions of parasite 285 
multiplication and host response to parasite load measured at a single point in time, and we 286 
have used these predictions to identify mechanistic determinants of parasite load in malaria. 287 
Our approach is based on clearly defined assumptions, but as with any attempt to model 288 
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complex biology, alternative approaches are possible. We cannot, at present, propagate 289 
uncertainty throughout the sequential stages of the model fitting, prediction of parameter 290 
estimates in individual subjects, and association of these parameter estimates with real 291 
variables. However, estimating the dynamics of parasite load allows us to make inferences 292 
about disease biology and mechanisms associated with PGI which could not have been made 293 
using only direct measurements. Our mechanistic validation suggests that the relative 294 
estimates of latent variables are accurate enough to be useful, providing proof-of -principle 295 
that pathogen load dynamics can be estimated in humans. This approach could be refined and 296 
expanded to identify additional genetic and serological determinants of pathogen load 297 
dynamics. The latter should be identified prospectively, since use of convalescent samples 298 
may introduce confounding. 299 
Parasite load is only one of the factors associated with severe malaria and its interpretation is 300 
dependent on epidemiological context10,15,29. Variations in the host response, naturally 301 
acquired immunity, and the expression of  P. falciparum erythrocyte membrane protein 1 302 
(PfEMP1) variants are also important determinants of severity and of disease phenotype10,15. 303 
We have previously suggested that variation in the dynamics of parasite load may explain 304 
why cerebral malaria and severe anaemia occur with parasites expressing the same PfEMP1 305 
variants10, and our model-based approach predicted that slower growth and longer duration of 306 
illness may distinguish severe anemia from cerebral malaria.     307 
The importance of pathogen load and the dynamic nature of host-pathogen interactions are 308 
often omitted from studies of life-threatening infectious diseases in humans3. Much of our 309 
understanding of the host-pathogen interactions comes from comparisons between 310 
individuals at the point of clinical presentation, despite the fact that they may be at different 311 
stages in the dynamic process of infection. This can result in seemingly paradoxical 312 
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observations such as high levels of TNF or low levels of platelets associated with severe 313 
malaria15,16, whilst evidence also indicates that TNF and platelets mediate defense against 314 
malaria parasites5,6,15-17. Considering the dynamic nature of the host-parasite interaction may 315 
explain these paradoxes and identify protective mechanisms more efficiently.  316 
We identified several mechanisms which might be considered as prototypes for host-directed 317 
therapy in malaria. Inhibition of type-1 interferon or CXCL10 signalling with inhibitory 318 
antibodies or small molecules might be strategies to enhance control of parasite load. The 319 
therapeutic potentials of cathepsin G and MMP9 may be counterbalanced by risk of collateral 320 
tissue damage, but selective targeting of receptors on the erythrocyte surface may be a useful 321 
paradigm for both treatment and prevention of malaria. 322 
Our approach could be applied to some other infectious diseases in which pathogen load can 323 
be measured and for which we do not have effective treatments, including emerging viral 324 
infections like Ebola, and possibly highly resistant bacterial pathogens, for which host-325 
directed therapies may life-saving2.   326 
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METHODS 327 
Subjects and laboratory assays 328 
We used data from all of the malariatherapy patients reported by Dietz et al.4 and from all 329 
139 Gambian subjects reported in our previous studies11,51,52 who had all of the following 330 
data available: age, parasite biomass estimate, plasma TNF concentration, duration of illness 331 
and severity of illness. No subjects were excluded after this selection, and all available data 332 
was included in analyses, with the exception that one outlier was excluded from parasite gene 333 
expression analysis. As described previously11,51,52, Gambian children (<16 years old) were 334 
recruited with parental consent from three peri-urban health centres in the Greater Banjul 335 
region, from August 2007 through January 2011 as part of a study approved by the Gambia 336 
Government/MRC Laboratories Joint Ethics Committee, and the Ethics Committee of the 337 
London School of Hygiene and Tropical Medicine. P. falciparum malaria was defined by 338 
compatible clinical symptoms in the presence of ≥5000 asexual parasites/µL blood, and any 339 
children suspected or proven to have bacterial co-infection were excluded. Severe malaria 340 
was specifically defined by the presence of prostration (SM1) or any combination of three 341 
potentially overlapping syndromes (cerebral malaria (CM), severe anemia (SA, hemoglobin 342 
<5 g/dL), and hyperlactatemia (blood lactate >5 mmol/L) - collectively SM2)11,51-53. Clinical 343 
laboratory assays, measurements of plasma TNF and IL-10 by Luminex, measurements of 344 
gene expression by RT-PCR, and estimation of total parasite biomass from PfHRP2 ELISA 345 
have been previously described11,52. Subject-level data from these Gambian children is 346 
available as Supplementary Dataset 1. 347 
 348 
Statistical analyses 349 
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Statistical analyses were undertaken using the R statistical software54 and GraphPad Prism 350 
(GraphPad Software, Inc.). Directly measured continuous variables were compared between 351 
groups using unpaired or paired student’s t-test (when normally distributed) and the Mann-352 
Whitney or Wilcoxon matched pairs tests (when normal distribution could not be assumed), 353 
and ANOVA or Kruskal-Wallis test for comparison across multiple groups. Associations 354 
between measured variables and latent variables were assessed using generalised additive 355 
models (GAM55, with the R package “mgcv”); the generalised cross-validation score and 356 
explained variance were used to select the best GAM once all model terms had significant 357 
effects (P<0.05). It was not possible to propagate uncertainty estimates through all stages 358 
from model development, calibration to the Gambian data, and prediction of latent variables 359 
in individual subjects, and so statistical analyses of latent variable were undertaken using 360 
their predicted values without any measure of uncertainty, and using non-parametric 361 
methods. Correlations between predicted values of latent variables and measured variables 362 
were done using Spearman correlation.  363 
All hypothesis tests were two-sided with alpha = 0.05 unless specifically stated otherwise. 364 
One-sided testing was only used when justified by small sample size and a strong a priori 365 
hypothesis for the direction of effect. We did not adjust for multiple hypothesis testing, 366 
except in the case of gene expression analyses where false-discovery rate was controlled 367 
using the Benjamini-Hochberg method. Dose-response curves were fitted using asymmetrical 368 
sigmoidal five-parameter logistic equation in GraphPad Prism.  369 
 370 
Model relating parasite multiplication, host response and parasite load 371 
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A process-based, stochastic simulation model was devised to reproduce the clinical data 372 
collected from the Gambian children. This was achieved by combining the information in the 373 
Gambian data with a model describing the first wave of parasitemia in non-immune adults 374 
who were deliberately infected with P. falciparum malaria to treat neurosyphilis 375 
(“malariatherapy”)4. These malariatherapy data, from the pre-antibiotic era, are the main 376 
source of information on the within-host dynamics and between-host variation in the course 377 
of parasitemia in untreated malaria infections. The model of Dietz et al.4 was modified and 378 
extended in order to be applied to the Gambian data, and we made the assumption that the 379 
Gambian children presented to hospital prior to the first peak of parasitemia. 380 
 381 
Model of ascending parasitemia in malariatherapy subjects. The model relates parasite 382 
density after each 2-day asexual blood stage cycle (P(t+2)) to the parasite density at the end of 383 
the previous cycle (P(t)) by the following equation: 384 
𝑃(𝑡+2) = 𝑃(𝑡). 𝑚. 𝑆𝑐(𝑡) 385 
The host-specific parasite multiplication rate, m, is a property of both parasite and host, 386 
allowing for growth-inhibition by constitutive factors; the proportion of parasites that will 387 
survive the effects of the density-dependent host response in the present cycle is Sc: 388 
𝑆𝑐(𝑡) =
1
1 + (
𝑃(𝑡)
𝑃𝑐
)
 389 
 390 
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, where Pc is the host-specific parasite load threshold at which the host response is strong 391 
enough to inhibit 50% of parasite growth in that cycle. Parasite growth inhibition (PGI(t)) is 392 
defined as 1-Sc(t). 393 
Consistent with the original Dietz model, P(0) was set to 0.003 parasites/µl
4. 394 
The original Dietz model included an additional parameter, Sm, to help describe the decline in 395 
parasitemia after the peak of the first wave. Sm is the proportion of isogenic parasites 396 
surviving an additional density- and time-dependent host response, which might represent 397 
adaptive immunity (4). Estimates of the range of values of Sm in the Dietz dataset and model 398 
were used when simulating data but since this parameter has little influence on parasite 399 
densities prior to the peak it was not used to make subsequent predictions of m and Pc in 400 
individual Gambian subjects.  401 
At the explicit request of Klaus Dietz and Louis Molineaux, we hereby communicate the 402 
following correction regarding their assertion that the malariatherapy patients had not 403 
received any treatment4: it was later found that 47 of these patients had indeed received 404 
subcurative treatment, and that those patients had significantly higher parasite densities. This 405 
is unlikely to influence our analysis, because treatment would only be provided when 406 
malariatherapy patients became very unwell, presumably at maximum parasitemia, whereas 407 
we assume that most patients with naturally acquired infection likely present prior to the peak 408 
parasitemia that might occur in the absence of treatment.  409 
Fitting of the malariatherapy model to data from Gambian children.  Individual-level 410 
parameter estimates for the malariatherapy dataset were kindly provided by Klaus Dietz. The 411 
logarithms of these 97 estimates of m and Pc were well described by a multivariate normal 412 
distribution, providing a quantitative description of inter-individual variation in the dynamics 413 
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of the first wave of parasitemia. In order to use the Dietz model to simulate the Gambian 414 
data, a number of modifications and extensions were made. Some of these required 415 
estimation of additional parameters by comparing the model simulations with the Gambian 416 
data. Dietz et al. provided a statistical description of the parasite density at which first fever 417 
occurred (the “fever threshold”) in the form of the distribution of the ratio of threshold 418 
density to peak parasitemia. The median density at first fever was at 1.4% of peak density. 419 
We introduced the assumption that the onset of fever occurs at a particular threshold value of 420 
Sc, because fever is dependent on the production of cytokines like interleukin-6 and TNF, 421 
both components of the host response. This constitutes a process-based model for the onset of 422 
fever rather than a purely statistical one. Because individuals differ in their response to 423 
parasite load (captured through variation in Pc), this results in variation of parasite densities at 424 
first fever but ignores any potential variation among individuals with respect to magnitude of 425 
host response necessary to generate fever. The host response threshold for the onset of fever 426 
Sc
f = 0.86 was determined as the value of Sc calculated at 1.4% of the peak density of a 427 
simulated individual with the median parameter values. This yielded a distribution of fever 428 
ratios similar to the one described by Dietz et al.4, albeit with less variation.  429 
To simulate the time between onset of fever and clinical presentation we made use of the self-430 
reported duration of symptoms in the Gambian data. The model which was most consistent 431 
with these values assumed a gamma-distributed duration of symptoms in non-severe cases, 432 
and a possibility to present earlier in the case of more severe disease. Since parasite biomass 433 
is related to likelihood of having severe malaria11,12,56 the probability of early presentation on 434 
any day after onset of fever was set proportional to the (density-dependent) probability of 435 
having severe disease on that day. Scale (ζ) and shape (κ) parameters of the gamma 436 
distribution as well as the factor (ξ) for determining the probability of early presentation were 437 
estimated from the Gambian data. 438 
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We assumed that TNF production τ(t) increases monotonically with density dependent host 439 
response (1-Sc) and represented this relationship using a heuristic function of the form 440 
𝜏(𝑡) = 𝑎 + 𝑏 
(
 
 
1 − 
1
1 + (
−log (𝑆𝑐(𝑡))
𝜆∗ )
𝛾
)
 
 
 441 
 442 
, with free parameters a, b, λ* and γ estimated from the Gambian data.  443 
The Gambian children had on average higher parasite densities than the malariatherapy 444 
patients, which led to a bad fit of the original model to the Gambian data. This was overcome 445 
by introducing the assumption that the Gambian children had a different range of values of Pc 446 
to the adult malariatherapy patients. A factor π was therefore estimated by which the ln Pc 447 
value from the Dietz model was multiplied. This led to overall higher parasite densities upon 448 
presentation. However, our model uses parasite biomass and its relationship with disease 449 
severity to predict day of presentation, and there is an interaction between the mean ln Pc and 450 
the variation in ln Pc, as well as the proportion of severe malaria in the simulated Gambian 451 
population. Based on the relatively low malaria transmission in the Banjul area of The 452 
Gambia, we assumed that severe cases (defined by the presence of any of: prostration, 453 
hyperlactatemia, severe anemia or cerebral malaria) were over-represented by hospital-based 454 
recruitment and that in an unselected population of children of similar age to those in our 455 
dataset only approximately 5% of all malaria infections would be severe28,29. Therefore we 456 
estimated a factor δ by which the variance of ln Pc should be multiplied such that both rate of 457 
severity as well as the distribution of parasite biomass matched well after fitting our 458 
simulation to the Gambian data. 459 
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The free parameters ζ , κ, ξ,  a, b, λ*, γ,  π and δ (Supplementary table 11), together 460 
summarized as θ, were estimated by fitting model simulations to the information on TNF, 461 
parasite density, and duration of symptoms, for any given candidate parameterization, a total 462 
of 139 clinically presenting individuals were simulated from the model, which corresponds to 463 
the size of the Gambian dataset. An objective function L(θ) was calculated, and a simulated 464 
annealing algorithm (provided by the “optim” function in R) determined the value for θ 465 
which maximizes this function. The log-likelihood L (θ) was comprised of three separate 466 
objectives. The first objective represented the log-probability that the frequency of severe 467 
cases in the simulation was equal to an assumed 5%, employing a binomial likelihood, given 468 
the actual number of severe cases sampled in 139 simulated individuals. The second objective 469 
considered the overlap between the bivariate distribution of ln parasite density vs. ln TNF 470 
concentration in the simulated data compared to the Gambian dataset. An approximate 471 
numerical value for this partial log-likelihood was obtained as the log probability of the 472 
Gambian data (density and TNF) given a two-dimensional kernel density estimate of the 473 
simulation output as a likelihood model. Kernel density estimates were obtained using the 474 
“kde2d” function in the “MASS” package in R. In this calculation, the TNF/density data 475 
points of severe or prostrated Gambian patients entered the partial likelihood with a weight of 476 
1/11, to account for the oversampling of severe cases in the Gambian data. The third 477 
objective concerned the two-dimensional distribution of log density and duration since first 478 
fever. This partial log-likelihood was obtained using the same kernel-based approach 479 
described above, with weights of 1/11 for severe and prostrated cases. The overall log-480 
likelihood L (θ) was calculated as a weighted sum of the three partial log-likelihoods, with 481 
the log-probability of having the desired true severity rate weighted with a factor of 68, which 482 
ensured similar magnitude of the three partial log-likelihoods at the optimum. 483 
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The results of the fitting algorithm were visually confirmed to yield a good overlap of the 484 
joint distributions of density and biomass, the duration of symptoms, TNF and biomass 485 
between simulation and the Gambian children. Approximate confidence intervals for the 486 
parameter estimates were determined by employing a 2nd degree polynomial to estimate the 487 
curvature of the maximum simulated likelihood surface in the vicinity of the parameter point 488 
estimate, assuming independence of parameters.  489 
As in the original model of Dietz et al.4, peripheral parasite densities were used to determine 490 
the dynamic changes in parasitemia, implying a correlation between peripheral densities and 491 
total parasite biomass. Total parasite biomass per kg was calculated from the predicted 492 
parasite density by the equation 70,000 x 1.09 x predicted parasite density in parasites/µL, as 493 
has been determined previously for uncomplicated malaria cases in the Gambian dataset11.  494 
Deterministic relationships between observable and latent variables. The range of values of 495 
m and ln Pc in a simulated population of 2000 patients were determined and each divided into 496 
50 equally spaced increments in order to generate 2500 possible combinations of m and ln Pc 497 
for which all model outcomes were determined in order to visualize their relationships. For 498 
the purpose of this analysis, the time-dependent adaptive immune response parameters 499 
(which comprise Sm) were set for all subjects at their respective population median values. 500 
The model of Dietz et al. makes use of discrete 2 day time intervals4, corresponding to the 501 
duration of the intraerythrocytic cycle in a highly synchronised infection. However, naturally 502 
acquired infections are rarely this synchronous and the time since infection of our Gambian 503 
patients is an unknown continuous variable. In order to cope with this we assumed that the 504 
relationship between predicted outcome variables (parasite biomass, duration of illness and 505 
TNF concentration) and explanatory variables (m and Pc) could be approximated by 506 
smoothed GAM. We used the GAM to estimate values of m, Pc and parasite growth 507 
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inhibition (PGI, 1-Sc) in the Gambian children, based on their known total parasite biomass, 508 
duration of symptoms and TNF concentration. 509 
Predicting severe anemia and IL-10 concentrations 510 
We used the data from the Gambian children to predict hemoglobin and IL-10 concentrations 511 
as continuous variables, using GLM with predicted Pc, predicted m, and age as explanatory 512 
variables. We then simulated a population of 50,000 1-year olds with malaria, allowing for 513 
normal variation in baseline hemoglobin concentration57, and adjusting Pc values according to 514 
a linear relationship between predicted ln Pc and age in the Gambian children. To predict the 515 
occurrence of severe anemia, we calculated the proportion of subjects estimated to have 516 
hemoglobin <5g/dL, and for these we calculated IL-10 concentrations as a continuous 517 
outcome. 518 
RNA-sequencing and data analysis 519 
We used RNA-sequencing data from all 24 subjects who were included in our previously 520 
reported study19 and had data to allow estimation of parasite growth inhibition and 521 
multiplication rate. RNA extraction, library preparation, sequencing and downstream 522 
analysis, including adjustment for leukocyte and parasite developmental stage mixture, have 523 
all been previously described19.    524 
The association of gene expression with m and PGI was determined using a generalized linear 525 
model approach in edgeR, allowing adjustment for leukocyte and parasite developmental 526 
stage mixture. Coefficients and P-values were calculated for the relationships between 527 
adjusted log gene expression and PGI for all detected genes. False discovery rate (FDR) was 528 
then computed using the Benjamini-Hochberg approach and FDR below 0.05 was considered 529 
to be significant in the initial analysis. FDRs between 0 and 0.1 were considered to indicate 530 
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consistent findings when comparing associations obtained under different model 531 
assumptions. Gene ontology (GO) terms were obtained from Bioconductor packages 532 
“org.Hs.eg.db” and “org.Pf.plasmo.db”. Fisher’s exact test was used to identify significantly 533 
over-represented GO terms from gene lists. The background gene sets consisted of all 534 
expressed genes detected in the data set. Enrichment analysis for biological process terms 535 
was carried out using the "goana()" function in edgeR. Using groups of genes significantly 536 
positively or negatively correlated with PGI, Ingenuity Pathway Analysis (Qiagen) was used 537 
to identify networks of genes functionally linked by regulators, interactions or downstream 538 
effects, which were visualized as radial plots centered around the most connected network 539 
member. The weighted gene co-expression network analysis (WGCNA) tool47 was used to 540 
construct modules of highly co-expressed parasite genes, based on analysis of 23 samples 541 
(sample HL_478 was removed as an outlier in parasite RNA-seq analysis) as described 542 
previously19. Module eigengene values for each subject were correlated with predicted m, 543 
using Spearman correlation.  544 
Parasite culture, growth and invasion assays 545 
P. falciparum 3D7 strain was used in continuous culture for all of the experiments unless 546 
otherwise stated. Asexual blood stage parasites were cultured in human blood group A red 547 
cells, obtained from the National Blood Service, at 1-5% hematocrit, 37°C, 5% CO2 and low 548 
oxygen (1% or 5%) as described previously58,59. Growth medium was RPMI-1640 (without 549 
L-glutamine, with HEPES) (Sigma) supplemented with 5 g/L Albumax II (Invitrogen), 147 550 
µM hypoxanthine, 2 mM L-glutamine, and 10 mM D-glucose. Parasite developmental stage 551 
synchronization was performed using 5% D-sorbitol to obtain ring stage parasites or Percoll 552 
gradients for schizont stage enrichment58,60. For growth assays, schizonts were mixed at <1% 553 
parasitemia with uninfected erythrocytes at 2% final hematocrit. Cathepsin G (Abcam) or 554 
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recombinant active MMP9 (Enzo) were added for 72 hour incubation to allow two replication 555 
cycles. Growth under each condition was calculated relative to the average growth in 556 
untreated samples. Invasion assays were performed by adding parasites synchronised at the 557 
schizont stage to target erythrocytes and incubating for 24 hours. Cathepsin G and MMP9 558 
were either pre-incubated with the target cells overnight followed by four washes with RPMI 559 
to completely remove them, or they were added directly to the culture of schizonts with target 560 
erythrocytes for 24 hours. The same protocol was followed for other P. falciparum strains 561 
except Dd2, for which magnetic purification was used to purify schizonts61. For combined 562 
treatments, cathepsin G was added to target erythrocytes and MMP9 was added at the same 563 
time as schizonts.  564 
Flow cytometry for parasitemia and erythrocyte surface receptor expression 565 
Flow cytometry was performed using a BD LSR Fortessa machine and analysis was 566 
conducted using FlowJo v10 (TreeStar Inc.), and gating strategies are show in Supplementary 567 
Figure 5. To assess parasitemia, 1µl of sample at 50% hematocrit was stained with Hoechst 568 
33342 (Sigma) and dihydroethidium (Sigma) and then fixed with 2% paraformaldehyde 569 
(PFA) before flow cytometry as previously described62. Erythrocyte surface receptor 570 
expression was assessed by median fluorescence intensity of erythrocytes labelled with 571 
monoclonal antibodies or by comparison with isotype control antibodies (Supplementary 572 
Table 12). Briefly, erythrocytes were washed twice before resuspending at 50% haematocrit, 573 
of which 1-2µl was stained in 100µl of antibody cocktail in FACS buffer (2% fetal bovine 574 
serum, 0.01% sodium azide in PBS) for 30 minutes in the dark on ice. Samples were washed 575 
twice in FACS buffer and then fixed in 300µl FACS buffer with 2% paraformaldehyde. 576 
Surface receptor loss was calculated from the difference between the treated and untreated 577 
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sample median fluorescent intensities after the isotype control antibody fluorescence had 578 
been subtracted. 579 
Whole blood stimulation and Cathepsin G and MMP9 ELISA 580 
Whole blood was collected from 8 healthy adult donors and plated at 25% hematocrit, and 581 
incubated overnight with or without 1µM PMA (Sigma). Supernatant was collected to 582 
perform Cathepsin G (CTSG ELISA Kit-Human, Aviva Systems Biology) and MMP9 583 
(Legend Max Human MMP-9, Biolegend) ELISAs, and erythrocytes were collected for 584 
assessment of surface receptor expression. The same ELISA kits were used to measure 585 
cathepsin G and MMP9 in acute (day 0) plasma samples from children with malaria. 586 
 587 
C-reactive protein, Hepcidin, and complement Factor H ELISA 588 
Using plasma samples collected 28 days after infection, CRP was measured using the human 589 
Simple Step ELISA kit (Abcam) and hepcidin concentration was measured in subjects who 590 
had not received blood transfusion using the Hepcidin-25 bioactive ELISA kit (DRG), both 591 
according to the manufacturer’s instructions, with duplicate measurements when sufficient 592 
plasma was available. Complement Factor H assays were performed using an in-house 593 
ELISA as described63. 594 
Data availability 595 
Estimates of parameters determining within-host dynamics in the malariatherapy dataset were 596 
obtained from reference 4, whose corresponding author may be contacted at klaus.dietz@uni-597 
tuebingen.de. RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI 598 
(www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-6413. Individual subject-599 
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level data is available within the paper and its supplementary information files. All other data 600 
that support the findings of this study are available from the corresponding author upon 601 
reasonable request. 602 
Code availability 603 
The source code for the model simulating Gambian child subjects and examples of its use are 604 
presented as Supplementary Library File, Supplementary Example File.  605 
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FIGURE LEGENDS 606 
Fig 1. Estimating the dynamics of parasite load and host response in malaria.   607 
(a) Conceptual model of determinants of parasite load. (b) Schematic of relationships 608 
between parasite load, multiplication rate (m), Pc, and parasite growth inhibition (PGI) 609 
derived from the longitudinal malariatherapy dataset. (c) Correlation matrix for Pc, m, parasite 610 
biomass, duration of illness and TNF concentrations in 2000 simulated Gambian children 611 
(Spearman correlation, LOWESS fit lines). (d) Performance in simulated subjects of the best 612 
models to predict ln Pc and m, compared with predictions made using individual variables 613 
only. Boxes show median and interquartile range, whiskers extend 1.5-times the interquartile 614 
range or to limit of range, n=100 simulated datasets (each of 139 subjects). (e-i) Comparisons 615 
of parasite biomass (e), TNF (f), duration of illness (g), predicted m (h), predicted Pc (i), in 616 
139 Gambian children with uncomplicated (UM, n=64) or severe malaria (SM1, prostration, 617 
n=36; SM2, any combination of cerebral malaria, hyperlactatemia or severe anemia, n=39). 618 
Box and whiskers as in d; P for Kruskal-Wallis (above plots) and Mann-Whitney tests (UM 619 
vs SM2, within plot). (j, k) Correlation of predicted m (j) or Pc (k) with age, P for Spearman 620 
correlation, n=139.  621 
30 
 
Fig 2. Contribution of parasite load dynamics to severe malaria phenotype. (a, b) 622 
Comparison of predicted and actual hemoglobin (a, n=136) and IL-10 (b, n=139) 623 
concentrations in the Gambian children. Pearson correlation, shaded region, 95% CI of 624 
regression line. (c-i)  Comparisons of m, Pc, parasite biomass, days of illness, plasma TNF, 625 
plasma IL-10, and plasma TNF:IL-10 ratio, in Gambian children with cerebral malaria (CM, 626 
n=12) and simulated Gambian infants with severe anemia (SA, n=24). Boxes show median 627 
and interquartile range, whiskers extend 1.5-times the interquartile range or to limit of range.   628 
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Fig 3. The protective effect of platelets is revealed by estimating parasite growth 629 
inhibition. 630 
(a,b) Comparisons of PGI (a) and platelet count (b) in 139 Gambian children with 631 
uncomplicated (UM, n=64) or severe malaria (SM1, prostration, n=36; SM2, any 632 
combination of cerebral malaria, hyperlactatemia or severe anemia, n=39 (platelet data 633 
missing from 4 subjects)). (c) Correlation between platelet count and PGI (n=135) shows that 634 
low platelet count is associated with greater parasite growth inhibition. Boxes show median 635 
and interquartile range, whiskers extend 1.5-times the interquartile range or to limit of range; 636 
P for Kruskal-Wallis (above plots) test (a, b) and for Spearman correlation (c).  637 
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Fig. 4 Transcriptional correlates of parasite growth inhibition 638 
(a) Volcano plot showing association between gene expression and parasite growth inhibition 639 
after adjustment for leukocyte mixture in a linear model. Log fold change (log FC) is the 640 
coefficient of log adjusted gene expression vs. parasite growth inhibition. Positive log FC 641 
indicates that increasing gene expression is associated with increasing parasite growth 642 
inhibition. Negative log FC indicates that increasing gene expression is associated with 643 
decreasing parasite growth inhibition. P calculated using two-sided likelihood ratio test, 644 
adjusted for multiple testing using the Benjamini-Hochberg method: false discovery rate 645 
adjusted P <0.05 (FDR) is considered significant (above dashed line, colored circles). The 10 646 
significant genes with greatest positive and negative log FC are labelled. Analyses based on 647 
data from n=24 subjects. (b,c) Primary networks derived from the genes significantly 648 
associated with PGI, with positive (b, n=26) and negative (c, n=25) log FC.   649 
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Fig. 5 Effects of cathepsin G and MMP9 on parasite growth and expression of 650 
erythrocyte invasion receptors  651 
(a) Effect of cathepsin G (18µg/mL, n=5) and MMP9 (16µg/mL, n=3) or no treatment (n=8) 652 
on in vitro growth of P. falciparum 3D7 (n are biological replicates, results representative of 653 
two independent experiments). (b) Effect of cathepsin G (18µg/mL) and MMP9 (18µg/mL) 654 
on erythrocyte invasion of P. falciparum 3D7 when added directly to schizonts and donor red 655 
cells, or when pre-incubated (PT) with donor red cells before washing and adding to 656 
schizonts (n=3 biological replicates per condition, representative of two independent 657 
experiments). (a, b) Show mean (95% CI) and P for two-sided unpaired t-test. (c) Cathepsin 658 
G and MMP9 concentrations in plasma from healthy donor whole blood (n=8) unstimulated 659 
or stimulated with 1µM PMA, and from Gambian children with P. falciparum malaria 660 
(n=34). Bars show median, P for two-sided Wilcoxon matched pairs test. (d-e) Dose effects 661 
on growth inhibition by MMP9 against P. falciparum 3D7 (d), and invasion inhibition by 662 
cathepsin G pre-treatment against four parasite strains (e) (n=3 biological replicates per dose, 663 
mean (95% CI) and P for linear trend, each result representative of two independent 664 
experiments). (f) Additive effect of Cathepsin G 1µg/mL and MMP9 1µg/mL against P. 665 
falciparum 3D7 invasion (n=4 biological replicates per condition, mean (95% CI) and P for 666 
ANOVA, representative of three independent experiments). (g) Dose response for erythrocyte 667 
surface receptor cleavage by cathepsin G (n=3 biological replicates per dose, mean +/- 668 
standard error, asymmetric 5-parameter logistic regression fit lines, representative of two 669 
experiments). (h) Effect of PMA stimulation of healthy donor (n=8) whole blood on 670 
erythrocyte surface receptor expression assessed by fluorescence intensity (P for two-sided 671 
Wilcoxon matched pairs test). (i) Comparison of proportion of erythrocytes with detectable 672 
receptor expression in acute (day 0) and convalescent (day 28) samples from Gambian 673 
children with malaria (n=6, P for one-sided Wilcoxon matched pairs test).  674 
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Figure 6. Parasite gene expression modules associated with predicted multiplication 675 
rate. (a,b) Violin plots showing comparison of mutation insertion scores (a) and mutation 676 
fitness scores (b) between modules associated with predicted multiplication rate 677 
(PF3D7_1136000, n=138 genes; PF3D7_1238300  n=42 genes) and all other genes 678 
(n=3421). (Violin plots indicate distribution of data (kernel density estimates) and median 679 
(red circle); P for comparison between each module and all other genes using a two-sided 680 
Mann-Whitney test). 681 
  682 
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